Respiratory Pathogen Testing Kits Market Expected to Reach $3.7 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Respiratory Pathogen Testing Kits Market," The respiratory pathogen testing kits market was valued at $2.2 billion in 2021, and is estimated to reach $3.7 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031.

The respiratory pathogens test is a highly specific and sensitive multiplex PCR for the nucleic acid detection of SARS-Cov-2, Influenza A, Influenza B, or other respiratory viruses. It can test respiratory pathogens that may help providers diagnose patients and give appropriate therapy options by using one nasal swab. As the rapid antigen tests deliver the results faster, the molecular respiratory tests also have significantly higher sensitivity and specificity for the testing. These kits are mainly used in the detection and identification of specific pathogen nucleic acids from individuals exhibiting signs and symptoms of respiratory infection. It further aids in proper diagnosis. It is used for the detection of various respiratory viruses and bacterial pathogens like Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza B, Human Parainfluenza Virus (HPIV) 1, Human Parainfluenza Virus (HPIV) 2, Human Parainfluenza Virus (HPIV) 3, Human Parainfluenza Virus (HPIV) 4, Rhinovirus/Enterovirus, Human Metapneumovirus (HMPV), Human Respiratory Syncytial Virus (HRSV) A, Human Respiratory Syncytial Virus (HRSV) B, Adenovirus, Coronavirus, Human Bocavirus, Chlamydophila pneumoniae and Mycoplasma pneumonia.

The Respiratory Pathogen Testing Kits Market Trends such as rise in prevalence of microbial infections in the form of common cold, influenza, tuberculosis, bronchitis, pneumonia, and the latest COVID-19, increase the production of respiratory pathogen testing kits, and surge in research and development funded by the government of various countries drive the growth of the Respiratory Pathogen Testing Kits Market Size. For instance, according to the data by Rochester Regional Health, a total of 19,713 influenza-related hospitalizations were reported between October 1, 2019 and March 28, 2020. Moreover, surge in geriatric population and technological advancements in respiratory diagnostic systems, surge in testing facilities, widespread use of kits in testing, increase in healthcare expenditure by the government authorities and availability of on-the-spot testing also helps in the growth of the Respiratory Pathogen Testing Kits Market Size. However, reimbursement concerns over the testing kits, unfavorable regulatory scenarios of the products used for testing, and increase in healthcare costs are expected to hinder the growth of the market. Conversely, high growth potential in untapped emerging economies is expected to create lucrative opportunities for the market.

The respiratory pathogen testing kits market is segmented on the basis of product type, application, end user and region. On the basis of product type, the market is bifurcated into RT PCR kits, lateral flow test kits, ELISA kits and others. On the basis of application, the market is classified into influenza virus infection, respiratory syncytial virus infection and others. On the basis of end user, the market is classified into hospitals, diagnostic centers and others. Region wise, the market is studied across North America, Europe, Asia-Pacific and LAMEA.

On the basis of product type, the market is classified into RT PCR kits, lateral flow test kits, ELISA kits and others. The ELISA kits segment is projected to exhibit the largest Respiratory Pathogen Testing Kits Market Share during the forecast period, owing to increase in the prevalence of respiratory microbial infections among the population, increase in the healthcare expenditure and increase in the adoption of respiratory infections diagnostic products for diagnosis.

On the basis of application, the market is classified into influenza virus infection, respiratory syncytial virus infection and others. The influenza virus infection segment is anticipated to have largest Respiratory Pathogen Testing Kits Market Share, owing to upsurge in number of patients of infectious diseases and increase in the number of diagnosis procedures of the respiratory diseases and increase in the number of research and development activities for the disease testing.

Moreover, the surge in testing facilities, the widespread use of kits in testing, and the availability of on-the-spot testing kits also helps in the growth of the market.

On the basis of end user, the market is classified into hospitals, diagnostic centers and others. The diagnostic centers segment is anticipated to grow at the highest rate for the Respiratory Pathogen Testing Kits Market Forecast period, owing to increase in the number of hospitals and diagnostic centers, increase the research activities of testing of the respiratory pathogens. Moreover, the rise in number of specialty clinics also contributes toward the growth of the Respiratory Pathogen Testing Kits Industry.

On the basis of region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). In 2021, North America was the dominant region and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of respiratory diseases, increase in the number market players in the Respiratory Pathogen Testing Kits Industry and surge in the testing facilities in the region. However, Asia-Pacific is expected to witness the highest CAGR during the Respiratory Pathogen Testing Kits Market Analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of infectious diseases.

Key Findings of The Study

• By product type, the lateral flow test kits segment accounted for the major share of the respiratory pathogen testing kits market in 2021.
• By application, the influenza virus infection segment is anticipated to grow with the highest CAGR throughout the forecast period.
• By end user, the diagnostic centers segment is anticipated to grow with the highest CAGR throughout the forecast period.
• By region, North America occupied major share of the respiratory pathogen testing kits market in 2021.